The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
The latest report by IMARC, titled “ ProteinDetection&QuantificationMarket:GlobalIndustryTrends,Share,Size,Growth,Opportunity andForecast2023-2028
” " the global protein detection & quantification market reached a value of US$ 2.5 Billion in 2022.
Protein detection and quantification is a method that is generally adopted by scientific researchers to investigate various types of biological processes. It involves the quantification of the total protein concentration in a sample in order to determine the characteristics and content of the protein. Consequently, it is an essential method to understand post-translational modifications as it helps in deciphering the functions of peptide networks that is widely adopted in the field of medicine and cell biology. Some of the commonly used techniques for protein detection and quantification include western blot analysis, enzyme-linked immunosorbent assay (ELISA), bicinchoninic acid (BCA) and Bradford assays and nanoparticles and nanopore-based methods.
Request Free Sample Report:
https://www.imarcgroup.com/protein-detection-quantification-market/requestsample
The global market is primarily driven by the increasing prevalence of infectious diseases among the masses. This can be attributed to the rising need for the development of preventive and therapeutic strategies to understand the role of protein in the progression of these diseases. Due to the rapid outbreak of coronavirus disease (COVID-19), there has been a considerable increase in the adoption of protein detection and quantification methods across the globe. Moreover, the rising government funding for extensive research and development (R&D) activities in the field of proteomics is providing an impetus to the market growth.
Along with this, continual advancements in protein technology and the widespread introduction of advanced test kits and systems for laboratory analyses are impacting the market favorably. Other factors, including continual developments in the pharmaceutical and genomics industries, the growing number of research laboratories and clinical trials, and the increasing investments to upgrade the existing healthcare infrastructure, are also positively influencing the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 4.4 Billion by 2028, exhibiting a CAGR of 9.2% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
MarketSummary:
BreakupbyProduct:
• Kits and Reagents/Consumables
• Instruments
• Services
BreakupbyTechnology:
• Colorimetric Assays
• Immunological Methods
• Chromatography
• Mass Spectrometry
• Spectroscopy Instruments
• Others
BreakupbyApplication:
• Drug Discovery and Development
• Clinical Diagnosis
• Others
BreakupbyEndUser:
• Academic Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research Organization
• Others
BreakupbyRegion:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
CompetitiveLandscapewithKeyPlayers:
• Agilent Technologies Inc
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• General Electric Company
• Inanovate Inc.
• Merck KGaA
• PerkinElmer Inc.
• RayBiotech Life Inc.
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
ViewFullReportwithTOC&ListofFigure:
https://www.imarcgroup.com/protein-detection-quantification-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
